About ProSomnus Sleep Technologies
ProSomnus is the pioneer and global leader in Smart Sleep Medicine™, delivering precision, non-CPAP Oral Appliance Therapy (OAT) for Obstructive Sleep Apnea (OSA), with integrated multi-night physiologic monitoring enabled by its RPMO2 platform. A serious medical disease affecting over 1 billion people worldwide, OSA is linked to life-threatening comorbidities including heart failure, stroke, and type 2 diabetes.
By integrating precision-engineered intraoral medical devices with advanced Remote Patient Monitoring (RPM) and data-driven diagnostics, ProSomnus is redefining the standard of care. Our platform is designed to provide continuous, nightly clinical insights that ensure superior adherence and validated patient outcomes. Non-invasive and patient-preferred, ProSomnus devices have demonstrated exceptional efficacy and safety across a rigorous and growing body of clinical evidence. ProSomnus precision devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, and TRICARE, representing over 200 million covered lives globally. To find a provider near you, visit https://prosomnus.com/find-a-provider/.
Executive Team
Len Liptak, BA, MBA, PLD
Corporate Director, Founder & CEO
Sung Kim
Corporate Director, Founder & CTO
Jason Orchard
Corporate Director, CFO
Heather Whalen
Vice President, Global Marketing
Services
Gregory Vogel
Vice President, Global
Dental Sleep Medicine Sales
Stacey Kiel
Vice President, U.S.
Dental Sleep Medicine Sales
Jerry Vogel
Vice President, Government Affairs &
CareConnect
Ricardo dos Santos
Vice President, Business Development
Medical & Scientific Leadership
Edward T. Sall, MD, DDS
Medical Director
Erin Mosca, PhD
Director of Scientific and Medical Affairs
Mark T. Murphy, DDS,
D-ABDSM, FAASM
Director of Dental Sleep Medicine Education
Board of Directors
Len Liptak, BA, MBA, PLD
Corporate Director, Founder & CEO
Laing Rikkers
Executive Chair, Director, and Co-founder
Len Hedge
Director
Board of Directors
Laing Rikkers, Chairwoman. Ms. Rikkers has served as Director and Co-founder of ProSomnus Sleep Technologies since 2016, including serving as Chairman from 2016 to 2018 and 2019 to 2021, and Executive Chairman January 2022 to October 2023. Ms. Rikkers has served as Managing Director of HealthpointCapital LLC, a private equity firm and manager of the principal stockholders of ProSomnus, since 2004 and Managing Director of HealthpointCapital Management LLC from 2018 to 2022. Ms. Rikkers served as director of MicroDental Laboratories and BioHorizons Inc., a joint venture with Henry Schein Inc., and as a board observer for multiple growth stage, dental and healthcare companies. She received her BA from Harvard University and her MA degree from Teachers College, Columbia University.
Len Liptak, BA, MBA, PLD, Corporate Director, Founder & CEO. Len Liptak is the Chief Executive Officer and Founder of ProSomnus Sleep Technologies, a leading developer and manufacturer of precision, connected medical devices for the treatment of Obstructive Sleep Apnea. As a healthcare entrepreneur and executive leader, he has led the company’s growth across financing, product innovation, regulatory advancement, and commercialization, helping position ProSomnus at the forefront of modern sleep medicine. Prior to founding ProSomnus, Mr. Liptak held senior leadership roles at global healthcare companies including Stryker and 3M, where he developed deep expertise in medical device innovation, commercialization, and market development. He holds degrees from Brown University, the University of Minnesota, and Harvard Business School, as well as a continuing education credential in data science from Johns Hopkins University. Mr. Liptak is a co-inventor on 17 patents, a co-author of multiple scientific publications—including four peer reviewed articles in leading medical journals—as well as numerous scientific abstracts and clinical communications and has contributed to the development of more than 10 medical devices that have received FDA 510(k) clearance.
Len Hedge, Director and member of the Compensation and Nomination and Corporate Governance Committees. Mr. Hedge has served as a member of the Board of Directors of Convergent Dental, a privately owned dental equipment and technology company, since 2013, and as a member of the board of directors of ProSomnus Sleep Technologies since 2016. He formerly served as a director at MicroDental Laboratories, OrthoAccel, a privately owned dental device company, and Six Month Smiles, a private company providing dental aligners and braces. Prior to his retirement, Mr. Hedge served as Senior Vice President of Business Operations at Align Technology Inc. from 2007 to 2013. Mr. Hedge focused on the design and implementation of core business processes and cross-functional collaboration to support Align’s long-term goals and strategic initiatives. He served as Vice President of Operations at Align from 2002 to 2007 and also served as its Vice President of Manufacturing … from 1999 to 2002 and helped create Align’s world-class mass customized manufacturing technology and processes. He served as Vice President of Operations for Plynetics Express Corporation, a leading provider of product development and engineering services, from 1996 to 1998. From 1991 to 1996, he led the accelerated product development initiative at Beckman Instruments Diagnostic Systems Group as Manager for Prototype Manufacturing and Process Development. Prior to Beckman, Mr. Hedge led mechanical fabrication operations for 13 years at General Dynamics in Pomona California. Mr. Hedge received his BS from La Verne University.
Heather Rider, Director, Chairman of the Compensation Committee and member of the Nomination and Corporate Governance Committee. Ms. Rider has served on the board of directors of Intricon Corporation (Nasdaq: IIN), a joint development manufacturer of components for micro-medical technology, from 2020 to 2022, and has served on the board of directors of Inogen, Inc. (Nasdaq: INGN), a manufacturer of oxygen therapy technology, since 2014. From 2012 to 2013, Ms. Rider served as Vice President, Global Human Resources of Cymer, Inc., a publicly-traded supplier of light sources for semiconductor manufacturing that was acquired by ASML Holding NV in 2013. From October 2010 to September 2012, Ms. Rider served as Senior Vice President, Global Human Resources of Alphatec Holdings, Inc. (Nasdaq: ATEC), a medical device company focused on surgical treatment of spine disorders, and from 2006 to 2010, she served as Vice President, Human Resources of Intuitive Surgical, Inc. (Nasdaq: ISRG), a manufacturer of robotic surgical systems. From 2001 to 2005, Ms. Rider served as Senior Vice President of Global Human Resources of Sunrise Medical, Inc., a global manufacturer and distributor of durable medical equipment. From 1998 to 2001, Ms. Rider served as Vice President of Human Resources of Biosense Webster, a member of the Johnson & Johnson family of companies, and a medical device manufacturer. Ms. Rider earned her BA from Claremont McKenna College, and her MBA from Pepperdine Graziadio Business School.
Bill Johnson, Director and Chairman of the Audit Committee. Mr. Johnson has served as Director of ProSomnus Sleep Technologies since 2016, including serving as Chairman from 2018 to 2019 and has served as Chairman of the Audit Committee for ProSomnus Sleep Technologies from 2016 to 2018 and 2019 to present, and has been the Managing Director and Chief Financial Officer of HealthpointCapital Management, LLC since 2016. Mr. Johnson served as the Chief Executive Officer of MicroDental, Inc. from 2015 to 2016, and the Chief Financial Officer of MicroDental from 2013 to 2015. Mr. Johnson served as Chief Financial Officer for Harvest Meat from 2012 to 2013, interim Chief Financial Officer for Ryerson Inc. in 2012, Chief Financial Officer for Brinderson Engineers & Construction from 2009 to 2011, Chief Financial Officer of PNA Group in 2008 and SVP of Finance from 2007 to 2008. Earlier in his career, Mr. Johnson worked in a variety of roles at companies responsible for financial reporting and accounting, and began his career at Ernst & Whinney, CPA’s (now Ernst & Young) as an auditor. Mr. Johnson earned BS from Indiana University, Kelley School of Business, and his MBA with a concentration in Finance from Mercer University, Stetson School of Business. He is a Certified Public Accountant and a Certified Financial Planner.
Steven Pacelli, Director, Chairman of the Nomination and Corporate Governance Committee and member of the Audit Committee. Mr. Pacelli has held a variety of roles at Dexcom Ventures, including Executive Vice President and Managing Director since 2021, Executive Vice President of Strategy and Corporate Development from 2012 to 2021 and a variety of other roles since 2006. Prior to Dexcom, Steve served as a corporate attorney specializing in finance, mergers and acquisitions, and general corporate matters, and in an executive role as general counsel of several privately held companies. Mr. Pacelli serves on the board of directors of Biocom California, the largest and most experienced leader and advocate for California’s life science sector, and on the boards of directors of several nonprofit organizations and trade groups. Mr. Pacelli earned a BS from the University of California, Los Angeles, and a JD from the University of Virginia. He is a member of the State Bar of California.
Jason Orchard, Director and member of the Audit Committee. Mr. Orchard has been with Spring Mountain Capital (“SMC”), a private investment management firm specializing in alternative asset investing, since 2004 and has served as a Managing Director since 2008. During his time at SMC he has served as Investment Analyst, Chief Financial Officer, and Portfolio Manager. In 2007, he led the firm’s initial efforts into special situation and thematic investments that have become the foundation of the SMC Total Return Fund. Today, he manages the SMC Total Return Fund and serves on the Investment Committee for the SMC’s Total Return Fund, Private Capital Fund, and West Harlem Innovation Fund. Prior to joining SMC in 2004, he was a Senior Analyst for Rutherford Asset Management LLC, which actively managed an $800 million hedge fund of funds portfolio for a private family office. Mr. Orchard has also been associated with Stern Stewart & Company as a Senior Analyst in the Financial Institutions Group and Arthur Andersen, L.L.P. as a Senior Consultant in the Strategy, Finance, and Economics Group. Mr. Orchard graduated with honors from Villanova University with a BS in Finance and is a Chartered Financial Analyst.
ProSomnus Sleep Technologies (Headquarters)
5675 Gibraltar Drive
Pleasanton, CA 94588, USA
Phone: +1 844 537 5337
Email: [email protected]
ProSomnus Germany GmbH
Landsberger Str. 234
Gebäudeteil B, 4. OG
80687 München, Germany
Phone: +49 89 23719077
Email: [email protected]
ProSomnus Switzerland
Industriestrasse 14
5036 Oberentfelden, Switzerland
Phone: +41 (0)62 544 58 51
Email: [email protected]